Industry experts Dr. Amy Abernethy and Dr. Brad Hirsch have launched Highlander Health, a company focused on improving patient care through a more integrated approach to evidence generation and healthcare delivery. Highlander Health is structured into two main components: Highlander Health Institute, a public interest platform dedicated to research and innovation, and Highlander Health Partners, an investment arm designed to support growth in the healthcare sector. The company aims to bridge gaps in the industry by creating streamlined solutions for treatment evaluation, approval, and adoption.

The Highlander Health Institute will partner with healthcare systems and industry players to conduct rigorous research and develop innovative solutions. These solutions will be tested through clinician-led learning labs, with the results transparently shared to advance the field of personalized healthcare. By focusing on personalized care, technology enablement, and evidence generation, the Institute seeks to drive improvements in patient outcomes.

Highlander Health Partners, the investment arm, will provide financial backing and strategic resources to support companies that align with its mission. With a focus on technology-driven solutions, the firm aims to foster innovation in healthcare and improve efficiency. This new venture by Drs. Abernethy and Hirsch represents a significant step toward more effective, personalized patient care and widespread adoption of innovative treatments.

Click here to read the original news story.